Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Global collaboration signed for potential breakthrough diabetes therapy

Sep. 23, 2002

Acyline is safe and decreases serum gonadotropin and testosterone levels in humans

Sep. 23, 2002

IPD discloses aldose reductase inhibitors and their use in diabetic complications

Sep. 20, 2002

Evra birth control patch approved in E.U. and Canada

Sep. 20, 2002

Seasonale NDA accepted for review

Sep. 19, 2002

Schering-Plough presents new MCH antagonists for use in obesity

Sep. 19, 2002

Dyax schedules second phase II trial of DX-88 in hereditary angioedema

Sep. 18, 2002

SuperGen's decitabine awarded orphan drug status for sickle cell anemia

Sep. 18, 2002

Diachrome evaluated for ability to improve blood glucose control in type 2 diabetes patients

Sep. 17, 2002

Wyeth advances NSP-989 into the clinic

Sep. 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...